NRobotics Co

NRobotics Co EBITDA per osake

EBITDA per osake yhtiöstä NRobotics Co (138360.KQ) 16.10.2026 päivämäärällä on −20,14 KRW. Edellisenä vuonna EBITDA per osake oli −62,59 KRW — muutos −67,83 % (korkeampi).

EBITDA per osake

−20,14KRW

YoY

−67,83%

Viimeksi päivitetty:

EBITDA per osake yhtiöstä NRobotics Co on 2024 −20,14 KRW. EBITDA per osake yhtiöstä NRobotics Co oli 2023 −62,59 KRW. Se laskee −67,83% korkeampi edelliseen vuoteen verrattuna.

NRobotics Co EBITDA per osake historia

  • 3 vuotta

  • 10 vuotta

  • 25 vuotta

  • Maksimi

EBITDA per osake
Päivämäärä
EBITDA per osake
1.1.2017
26,34 KRW
1.1.2018
−174,73 KRW
1.1.2019
6,26 KRW
1.1.2020
−98,03 KRW
1.1.2021
20,05 KRW
1.1.2022
35,69 KRW
1.1.2023
−62,59 KRW
1.1.2024
−20,14 KRW
NRobotics Co EBITDA per osake historia
VUOSIEBITDA per osakeYoY
−20,14KRW−67,83%
−62,59KRW−275,36%
35,69KRW+78,03%
20,05KRW−120,45%
−98,03KRW−1 666,16%
6,26KRW−103,58%
−174,73KRW−763,47%
26,34KRW−86,17%
190,45KRW+104,36%
93,19KRW−63,25%
253,56KRW—

Hae nämä tiedot Eulerpool API:n kautta

100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia

NRobotics Co Osakeanalyysi

Mitä NRobotics Co tekee? NRobotics Co Ltd, trading under the ticker symbol 138360.KQ and identified by the ISIN KR7138360003, is a South Korean enterprise operating within the Materials sector, specifically in the Chemicals industry. The company maintains its corporate headquarters in Siheung, located in the Gyeonggi-Do province. As of the most recent data, the organization employs a workforce of 45 full-time staff members, reflecting its status as a small-to-medium sized entity in the chemical manufacturing landscape. NRobotics Co Ltd officially entered the public markets through an initial public offering on November 8, 2013, marking a significant milestone in its corporate history and financial transparency. The company’s primary business activity revolves around the manufacture and sale of cosmetic ingredients, serving a diverse range of clients in the beauty and personal care industries. Its product portfolio is extensive and technologically advanced, featuring bioconversion technology products, encapsulated products, natural extracts, and synthetic compounds. Among its notable offerings are specialized formulations such as Aquatouch L, a blend composed of glycerin, dimethicone, water, and lecithin, designed to enhance skin hydration and texture. Another key product is Silkytouch L, which combines water, dimethicone, glycerin, palmitoyl inulin, behenyl alcohol, and 1,2-hexanediol to provide smooth application and sensory benefits. The company also produces a range of phyto-based ingredients, including Phytoact Reliefer, which utilizes phaseolus radiates seed extract and avena sativa meal extract, alongside other active components like ethyhexylglycerin. Further innovations in the natural extract segment include Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir, and Actosome Deage, each targeted at specific cosmetic efficacy needs such as anti-aging and skin barrier support. In addition to its core cosmetic ingredient business, NRobotics Co Ltd has diversified its operations to include the provision of electronic materials, indicating a strategic expansion into adjacent high-tech sectors. This diversification underscores the company’s commitment to leveraging its chemical expertise across multiple industrial applications. Despite its relatively small employee base, the company’s focus on specialized, high-value ingredients and its presence in both cosmetic and electronic material markets position it as a niche player with potential for growth in specialized chemical supply chains. The company’s official web presence can be accessed at http://www.hjfm.co.kr/, where stakeholders and potential partners can find further details regarding its operations and product lines. NRobotics Co on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset NRobotics Co osakkeesta

Yhtiön NRobotics Co EBITDA per osake on −20,14 KRW vuonna 2024.

EBITDA per osake yhtiöstä NRobotics Co muuttui arvosta −62,59 KRW arvoon −20,14 KRW, mikä edustaa −67,83 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA per osake NRobotics Co:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA per osake jakaa EBITDAN liikkeeseen laskettujen osakkeiden lukumäärällä, näyttäen operatiivisen rahavoiton jaettuna osakemäärällä ennen poistoja ja rahoitusvaikutuksia.

Hae nämä tiedot Eulerpool API:n kautta

100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia

Tuloslaskelma — NRobotics Co

Kaikki tunnusluvut — NRobotics Co